The Cooper Companies, Inc. (1COO)
MTA
Closed
Aug 21, 2026
Day's Range
61.8452 wk Range
52.47Overview - 1COO - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
13.08B
P/E (Trailing)
‪62.61‬
PEG Ratio
‪-0.32‬
Price / Sales (TTM)
‪2.91‬
Price / Book
‪1.74‬
EV / EBITDA
‪17.23‬
Profitability
Gross Margin
‪67.99%‬
Profit Margin
‪5.57%‬
Operating Margin
‪-2.86%‬
Return on Assets
‪2.51%‬
Return on Equity
‪2.85%‬
Ownership
Shares Outstanding
194.91M
Float
193.67M
Held by Insiders
‪0.61%‬
Held by Institutions
‪109.22%‬
Price stats
Beta
‪0.82‬
50-Day Avg
‪61.35‬
200-Day Avg
‪63.54‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1COO - The Cooper Companies, Inc.
Peers - 1COO - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on MTA.
Profile Summary - 1COO - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
